1. Home
  2. YJ vs LGVN Comparison

YJ vs LGVN Comparison

Compare YJ & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yunji Inc. American Depository Shares

YJ

Yunji Inc. American Depository Shares

N/A

Current Price

$1.25

Market Cap

7.3M

ML Signal

N/A

Logo Longeveron Inc.

LGVN

Longeveron Inc.

N/A

Current Price

$1.75

Market Cap

7.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
YJ
LGVN
Founded
2015
2014
Country
China
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.3M
7.8M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
YJ
LGVN
Price
$1.25
$1.75
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $61.25
AVG Volume (30 Days)
★ 322.8K
67.8K
Earning Date
08-20-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 50.76
EPS
★ N/A
N/A
Revenue
N/A
★ $709,000.00
Revenue This Year
N/A
$46.15
Revenue Next Year
N/A
$396.46
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.11
$0.48
52 Week High
$13.97
$7.60

Technical Indicators

Market Signals
Indicator
YJ
LGVN
Relative Strength Index (RSI) 34.12 38.44
Support Level N/A $0.61
Resistance Level $1.51 $7.30
Average True Range (ATR) 0.20 0.23
MACD -0.03 0.03
Stochastic Oscillator 2.28 33.33

Price Performance

Historical Comparison
YJ
LGVN

About YJ Yunji Inc. American Depository Shares

Yunji Inc is a social e-commerce platform in China using a membership-based model that leverages the power of social interaction. The group offers high-quality products at attractive prices and incentivizes members to promote its platform and share products with their social contacts. It empowers prime emerging brands and manufacturers with a deep understanding of market trends and customer behavior to produce high-quality products to meet the demands of members. The company also developed several private labels in the mass consumption field, which are sold on its own platform as well as offered and sold through external channels. It operates in the PRC, and substantially all the Group's revenue is derived from within the PRC.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.

Share on Social Networks: